Title |
Prolonged Clinical Remission in Patients with Systemic Lupus Erythematosus
|
---|---|
Published in |
Journal of Rheumatology, August 2014
|
DOI | 10.3899/jrheum.131137 |
Pubmed ID | |
Authors |
Amanda J Steiman, Murray B Urowitz, Dominique Ibañez, Anjali Papneja, Dafna D Gladman |
Abstract |
Systemic lupus erythematosus (SLE) is typically a relapsing/remitting disease. However, some patients experience prolonged remission. These patients may provide further insights into SLE pathophysiology. In this study we characterize their clinical course. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 33% |
Canada | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 72 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 13% |
Student > Ph. D. Student | 8 | 11% |
Student > Bachelor | 8 | 11% |
Student > Master | 7 | 10% |
Student > Postgraduate | 6 | 8% |
Other | 16 | 22% |
Unknown | 18 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 53% |
Biochemistry, Genetics and Molecular Biology | 5 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Sports and Recreations | 1 | 1% |
Immunology and Microbiology | 1 | 1% |
Other | 5 | 7% |
Unknown | 20 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2022.
All research outputs
#1,981,631
of 25,377,790 outputs
Outputs from Journal of Rheumatology
#242
of 3,951 outputs
Outputs of similar age
#19,425
of 240,210 outputs
Outputs of similar age from Journal of Rheumatology
#3
of 54 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,951 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,210 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.